Impact of extrafine formulation single-inhaler triple therapy on health-related quality of life after three months of treatment in patients with asthma: the TriMaximize study

被引：0

作者：

Koczulla, Rembert ^{[1
,2
]}

Akyildiz, Berktan ^{[3
]}

Ulrik, Charlotte Suppli ^{[4
]}

Nachtigall, Detlef ^{[3
]}

Russell, Richard ^{[5
]}

Bogoevska, Valentina ^{[3
]}

Pohl, Wolfgang ^{[6
]}

Borucki, Tanja ^{[3
]}

Martini, Maurice-Dominique ^{[3
]}

Gessner, Christian ^{[7
]}

机构：

[1] Philipps Univ Marburg, Dept Pulm Med & Rehabil, Marburg, Germany

[2] German Ctr Lung Res, Marburg, Germany

[3] Chiesi GmbH Hamburg, Hamburg, Germany

[4] Copenhagen Univ Hosp Hvidovre, Dept Pulm Med, Hvidovre, Denmark

[5] Univ Oxford, Oxford, England

[6] Vienna Healthcare Grp, Karl Landsteiner Inst Clin & Expt Pneumol, Clin Hietzing, Vienna, Austria

[7] Pneumol Praxis Leipzig, Leipzig, Germany

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA2374

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[21] Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (vol 37, pg 3775, 2020)
Tabberer, Maggie
Jones, C. Elaine
Kilbride, Sally
Halpin, David M. G.
Lomas, David A.
Pascoe, Steven
Singh, Dave
Wise, Robert A.
Criner, Gerard J.
Lange, Peter
Dransfield, Mark T.
Han, MeiLan K.
Martinez, Fernando J.
Kaisermann, Morrys C.
Lipson, David A.
ADVANCES IN THERAPY, 2022, 39 (03) : 1446 - 1446
[22] TriOptimize VII: Improvement of health-related quality of life after 3 months treatmentwith extrafine single inhaler triple therapy in COPD patients in a real-world setting
Gessner, Christian
Javan, Sanaz Bahari
Hoevelmann, Raimund
Georges, George
Melchior, Kai
Criee, Carl-Peter
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[23] Improvement of asthma control after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Greulich, T.
Akyildiz, B.
Slawinska, R.
Wendt, A.
Bogoevska, V
Gessner, C.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[24] Impact of extrafine single-inhaler triple therapy on treatment adherence after 6 months of treatment in asthmatics: a real-world view from Germany
Trinkmann, Autoren F.
Akyildiz, B.
Grickschat, V
Borucki, T.
Gessner, C.
PNEUMOLOGIE, 2023, 77 : S35 - S36
[25] Change in asthma control after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Greulich, T.
Akyildiz, B.
Nachtigall, D.
Bogoevska, V
Gessner, C.
PNEUMOLOGIE, 2023, 77 : S29 - S29
[26] Single inhaler triple therapy in patients with COPD: response rates in health-related quality of life in the IMPACT Trial
Tabberer, Maggie
Jones, Christine Elaine
Kilbride, Sally
Criner, Gerard J.
Lange, Peter
Han, Meilan K.
Martinez, Fernando
Lipson, David A.
EUROPEAN RESPIRATORY JOURNAL, 2018, 52
[27] Trioptimize IV: Improvement of Health-Related Quality of Life in Patients with COPD Treated with Extrafine Single Inhaler Triple Therapy in a Real-World Setting
Gessner, C.
Criee, C.
Georges, G.
Javan, S. Bahari
Melchior, K.
Hoevelmann, R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[28] Improvement of treatment adherence after 3 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Gessner, C.
Akyildiz, B.
Grickschat, V
Borucki, T.
Trinkmann, F.
EUROPEAN RESPIRATORY JOURNAL, 2022, 60
[29] TriOptimize III: Extrafine single inhaler Triple Therapy in COPD improves health-related quality of life in a real-world setting in Germany
Hoevelmann, R.
Georges, G.
Javan, Bahari S.
Melchior, K.
Criee, C. P.
Gessner, C.
PNEUMOLOGIE, 2020, 74 : S43 - S43
[30] Change in lung function after 6 months of treatment with extrafine single-inhaler triple therapy in asthmatics: a real-world view from Germany
Gessner, C.
Akyildiz, B.
Wendt, A.
Licht, B.
Criee, C.
PNEUMOLOGIE, 2023, 77 : S36 - S36

← 1 2 3 4 5 →